NCT02467270 · Interventional trial
Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses
Overall registry status Completed
Phase 2
Conditions Myeloid Leukemia, Chronic, Chronic Phase
Delaware Valley sites
- Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory